DexCom Inc (NASDAQ:DXCM) experienced a daily loss of -2.21%, marking a 3-month loss of -18.56%. The company reported an Earnings Per Share (EPS) of 0.86. These figures raise the question: is DexCom ...
Despite a daily gain of 4.65% and an Earnings Per Share (EPS) of 0.86, DexCom Inc (NASDAQ:DXCM) has seen a 3-month loss of -19.52%. This raises the question: is DexCom's stock modestly undervalued?
EDINBURGH, Scotland--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the publication of a ...
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the FDA has cleared Stelo by Dexcom ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback